These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34999268)

  • 41. Transcranial DC stimulation modifies functional connectivity of large-scale brain networks in abstinent methamphetamine users.
    Shahbabaie A; Ebrahimpoor M; Hariri A; Nitsche MA; Hatami J; Fatemizadeh E; Oghabian MA; Ekhtiari H
    Brain Behav; 2018 Mar; 8(3):e00922. PubMed ID: 29541538
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of moderate- and high-intensity acute aerobic exercise on food reward and appetite in individuals with methamphetamine dependence.
    Zhou Y; Lu Y; Jin X; Liu J; Finlayson G; Zhou C
    Physiol Behav; 2019 Nov; 211():112649. PubMed ID: 31419449
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men: A Placebo-Controlled Randomized Clinical Trial.
    Coffin PO; Santos GM; Hern J; Vittinghoff E; Walker JE; Matheson T; Santos D; Colfax G; Batki SL
    JAMA Psychiatry; 2020 Mar; 77(3):246-255. PubMed ID: 31825466
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving.
    Ahmadi J; Sahraian A; Biuseh M
    Trials; 2019 Jul; 20(1):468. PubMed ID: 31362784
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment.
    Robertson CL; Ishibashi K; Chudzynski J; Mooney LJ; Rawson RA; Dolezal BA; Cooper CB; Brown AK; Mandelkern MA; London ED
    Neuropsychopharmacology; 2016 May; 41(6):1629-36. PubMed ID: 26503310
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Virtual Digital Psychotherapist App-Based Treatment in Patients With Methamphetamine Use Disorder (Echo-APP): Single-Arm Pilot Feasibility and Efficacy Study.
    Chen T; Chen L; Li S; Du J; Su H; Jiang H; Wu Q; Zhang L; Bao J; Zhao M
    JMIR Mhealth Uhealth; 2023 Jan; 11():e40373. PubMed ID: 36719727
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A mindfulness-based, stress and coping model of craving in methamphetamine users.
    Mutumba M; Moskowitz JT; Neilands TB; Lee JY; Dilworth SE; Carrico AW
    PLoS One; 2021; 16(5):e0249489. PubMed ID: 34003834
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intermittent theta burst transcranial magnetic stimulation for methamphetamine addiction: A randomized clinical trial.
    Su H; Chen T; Jiang H; Zhong N; Du J; Xiao K; Xu D; Song W; Zhao M
    Eur Neuropsychopharmacol; 2020 Feb; 31():158-161. PubMed ID: 31902567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Executive function moderates naltrexone effects on methamphetamine-induced craving and subjective responses.
    Lim AC; Grodin EN; Green R; Venegas A; Meredith LR; Courtney KE; Moallem NR; Sayegh P; London ED; Ray LA
    Am J Drug Alcohol Abuse; 2020 Sep; 46(5):565-576. PubMed ID: 32343625
    [No Abstract]   [Full Text] [Related]  

  • 50. Feasibility and acceptability of approach bias modification during methamphetamine withdrawal and related methamphetamine use outcomes.
    Manning V; Garfield JBB; Mroz K; Campbell SC; Piercy H; Staiger PK; Lum JAG; Lubman DI; Verdejo-Garcia A
    J Subst Abuse Treat; 2019 Nov; 106():12-18. PubMed ID: 31540606
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence.
    Heinzerling KG; Swanson AN; Kim S; Cederblom L; Moe A; Ling W; Shoptaw S
    Drug Alcohol Depend; 2010 Jun; 109(1-3):20-9. PubMed ID: 20092966
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protocol for the methamphetamine approach-avoidance training (MAAT) trial, a randomised controlled trial of personalised approach bias modification for methamphetamine use disorder.
    Garfield JBB; Piercy H; Arunogiri S; Lubman DI; Campbell SC; Sanfilippo PG; Gavin J; Hopwood M; Kotler E; George S; Okedara G; Piccoli LR; Manning V
    Trials; 2021 Jan; 22(1):21. PubMed ID: 33407781
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Negative moods correlate with craving in female methamphetamine users enrolled in compulsory detoxification.
    Shen W; Liu Y; Li L; Zhang Y; Zhou W
    Subst Abuse Treat Prev Policy; 2012 Oct; 7():44. PubMed ID: 23110820
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial.
    Acheson LS; Ezard N; Lintzeris N; Dunlop A; Brett J; Rodgers C; Gill A; Christmass M; McKetin R; Farrell M; Shoptaw S; Siefried KJ
    Drug Alcohol Depend; 2022 Dec; 241():109692. PubMed ID: 36399936
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation study.
    Ezard N; Clifford B; Dunlop A; Bruno R; Carr A; Liu Z; Siefried KJ; Lintzeris N
    BMJ Open; 2021 May; 11(5):e044696. PubMed ID: 34006547
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synergistic effect of combined transcranial direct current stimulation and Matrix ‎Model on the reduction of methamphetamine craving and improvement of cognitive ‎functioning: a randomized sham-controlled study.
    Fayaz Feyzi Y; Vahed N; Sadeghamal Nikraftar N; Arezoomandan R
    Am J Drug Alcohol Abuse; 2022 May; 48(3):311-320. PubMed ID: 35404725
    [No Abstract]   [Full Text] [Related]  

  • 57. A structured, telephone-delivered intervention to reduce methamphetamine use: study protocol for a parallel-group randomised controlled trial.
    Lubman DI; Manning V; Arunogiri S; Hall K; Reynolds J; Stragalinos P; Petukhova R; Gerhard R; Tyler J; Bough A; Harris A; Grigg J
    Trials; 2023 Mar; 24(1):235. PubMed ID: 36991490
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mindfulness-based relapse prevention combined with virtual reality cue exposure for methamphetamine use disorder: Study protocol for a randomized controlled trial.
    Chen XJ; Wang DM; Zhou LD; Winkler M; Pauli P; Sui N; Li YH
    Contemp Clin Trials; 2018 Jul; 70():99-105. PubMed ID: 29679670
    [TBL] [Abstract][Full Text] [Related]  

  • 59. State dependent effect of transcranial direct current stimulation (tDCS) on methamphetamine craving.
    Shahbabaie A; Golesorkhi M; Zamanian B; Ebrahimpoor M; Keshvari F; Nejati V; Fregni F; Ekhtiari H
    Int J Neuropsychopharmacol; 2014 Oct; 17(10):1591-8. PubMed ID: 24825251
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between rumination and drug craving in Chinese male methamphetamine use disorder patients with childhood trauma.
    Li D; Wang D; Ren H; Tian Y; Chen J; Zhu R; Li Y; Wang L; Zhang XY
    Child Abuse Negl; 2023 Oct; 144():106357. PubMed ID: 37459735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.